Metformine Eg

Metformin, the active ingredient in Metformine Eg, is a biguanide presented as an oral formulation for oral use. It is used to improve blood glucose control in patients with type 2 diabetes mellitus. GNH USA supplies Metformine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformine Eg is indicated for conditions affecting glucose metabolism and insulin sensitivity.

Type 2 diabetes mellitus: lowers fasting plasma glucose and HbA1c levels. Impaired glucose tolerance: helps delay progression to overt diabetes. Polycystic ovary syndrome: reduces insulin resistance and associated hyperandrogenism.

Metformine Eg may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: altered taste perception. - Loss of appetite: reduced food intake. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycemia: when combined with insulin or secretagogues. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: elevated liver enzymes. - Skin reactions: rash or Stevens‑Johnson syndrome. - Pancreatitis: inflammation of the pancreas.

Before initiating Metformine Eg, certain safety considerations should be observed.

Renal function: assess eGFR and avoid use if severely impaired. Lactic acidosis risk: contraindicated in hepatic failure or severe infection. Alcohol consumption: limit intake to reduce acidosis risk. Surgery or contrast studies: withhold metformin temporarily. Pregnancy: discuss potential risks with the prescriber. Store at ambient temperature: keep in the original pack, protect from moisture.

Metformine Eg can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal failure and lactic acidosis. - Cimetidine: raises metformin plasma concentrations. - Acute alcohol intoxication: heightens lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Thiazide diuretics: can elevate blood glucose levels. - ACE inhibitors/ARBs: may affect renal function, requiring monitoring.